Proteas head coach Mark Boucher Proteas coach Mark Boucher will wait for a new convenor of selectors before naming his Test captain.Cricket SA is yet to name a replacement for Linda Zondi as selector chief.Faf du Plessis stepped down at Test skipper in February, while Quinton de Kock is the limited overs captain.Proteas coach Mark…
Patience … it’s a virtue Pieter Malan has already shown he possesses at the highest level.Other attributes have clearly been spotted in him, too.In an interview with Sport24 earlier this year, veteran administrator and captain of the 1970 South African immortals, Ali Bacher, enthused: “I’m not sure where they found him. He can bat; his…
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.
You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f